resources

Entero Healthcare Solutions Ltd.

NSE: ENTERO

BSE: 544122

Sector: Consumer Services

Industry Group: Retailing

Industry: Pharmacy Retail

1,172.00-38.1 (-3.15%)

8 Jul, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Entero Healthcare Solutions Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2023	2024	2025	2026
Annual Reports	—	FY 2024	FY 2025	—
Quarterly Results	Dec	Mar Jun Sept Dec	Jun Sept Dec	—
Conference Calls	—	15Mar 6Jun 22Aug 19Nov	19Feb 4Jun 19Aug 20Nov	20Feb 2Jun
Presentations	—	8Mar 29May 31May 15Aug 13Nov	12Feb 8Aug 12Nov	12Feb 25May

Corporate Announcements and Regulatory Filings

Entero Healthcare Solutions Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate u/r 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026
Change in Management26 Jun 2026
Announcement under Regulation 30 (LODR)-Change in Management
Revision in tenure of re-appointment of Mr. Rajesh Shashikant Dalal (DIN: 03504969) and Ms. Sandhya Gadkari Sharma (DIN: 02005378) as Non-Executive Independent Directors of the Company.
Allotment of ESOP / ESPS26 Jun 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Board has approved allotment of 1,475 (One Thousand Four Hundred and Seventy-Five) Equity Shares of Rs. 10/- (Rupees Ten) each of the Company, to the eligible employee of the Company, upon ....
Outcome without intimation26 Jun 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On June 26, 2026
Outcome of Board Meeting held on June 26, 2026
Closure of Trading Window23 Jun 2026
Closure of Trading Window
Intimation of Closure of Trading Window
Resignation of Director12 Jun 2026
Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Mr. Kevin Rohitbhai Daftary as Non- Executive Nominee Director of the company w.e.f. Jun 12, 2026.
General11 Jun 2026
The Grant Of Fresh 17,500 (Seventeen Thousand Five Hundred) Employee Stock Options Under The Existing 'Entero Employee Stock Option Plan 2023'.
The grant of fresh 17,500 (Seventeen Thousand Five Hundred) Employee Stock Options under the existing 'Entero Employee Stock Option Plan 2023'.
Allotment of ESOP / ESPS11 Jun 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
The Board has approved the allotment of 3,420 (Three Thousand Four Hundred and Twenty) Equity Shares of Rs. 10/- (Rupees Ten) each of the Company, to the eligible employee of the Company, ....
Outcome without intimation11 Jun 2026
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting held on June 11, 2026
General28 May 2026
Clarification On Investor Queries Relating To Profit Attributable To Owners Of The Company And Minority Interest For The Quarter Ended 31St March 2026
Clarification on Investor Queries relating to profit attributable to owners of the Company and minority interest for the Quarter ended 31st March 2026
Reg.24(A)-Annual Secretarial Compliance27 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended March 31, 2026
Newspaper Publication27 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication for Audited Financial Results of the Company for the Quarter and Year ended March 31, 2026.
Analyst / Investor Meet26 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Recording of Earnings Call/ Conference Call
Allotment of ESOP / ESPS25 May 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
The Board has approved allotment of 7,240 (Seven Thousand Two Hundred Forty) Equity Shares of Rs. 10/- (Rupees Ten) each of the Company, to the eligible employees of the Company, upon exercise ....
General25 May 2026
The Board Approved The Re-Appointment Of Internal Auditor M/S. Ernst & Young LLP ('EY') For The Next Financial Year 2026-27.
The Board approved the re-appointment of Internal Auditor M/s. Ernst & Young LLP ('EY') for the next financial year 2026-27.
General25 May 2026
The Grant Of Fresh 7,300 (Seven Thousand Three Hundred) Employee Stock Options Under The Existing 'Entero Employee Stock Option Plan 2023'.
The grant of fresh 7,300 (Seven Thousand Three Hundred) Employee Stock Options under the existing 'Entero Employee Stock Option Plan 2023'.
Change in Management25 May 2026
Announcement under Regulation 30 (LODR)-Change in Management
the Board approved the re-appointment of Mr. Sujesh Vasudevan (DIN: 08240092), Mr. Rajesh Shashikant Dalal (DIN: 03504969) and Ms. Sandhya Gadkari Sharma (DIN: 02005378) as Non-Executive ....
Acquisition25 May 2026
Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of Vishal Surgicals and Vishal Surgicals & Medicals, a Partnership Firm, through its subsidiary company Sai Pharma Distributors Private Limited through Slump Sale / Business ....
Allotment of Equity Shares25 May 2026
Announcement under Regulation 30 (LODR)-Allotment
The Board has approved allotment of 7,240 (Seven Thousand Two Hundred Forty) Equity Shares of Rs. 10/- (Rupees Ten) each of the Company, to the eligible employees of the Company, upon exercise ....
Outcome of Board Meeting25 May 2026
Board Meeting Outcome for Outcome Of Board Meeting May 25, 2026
Outcome of Board Meeting May 25, 2026

Frequently Asked Questions

Where can I download the annual report of Entero Healthcare Solutions Ltd.?

Annual reports of Entero Healthcare Solutions Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Entero Healthcare Solutions Ltd.?

Quarterly earnings results and presentations of Entero Healthcare Solutions Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Entero Healthcare Solutions Ltd. publish earnings call transcripts?

Earnings call transcripts of Entero Healthcare Solutions Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Entero Healthcare Solutions Ltd.?

Investor presentations and annual day presentations of Entero Healthcare Solutions Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Entero Healthcare Solutions Ltd.?

Corporate announcements and regulatory filings of Entero Healthcare Solutions Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Entero Healthcare Solutions Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Entero Healthcare Solutions Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Entero Healthcare Solutions Ltd.?

The ISIN (International Securities Identification Number) of Entero Healthcare Solutions Ltd. is INE010601016. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Entero Healthcare Solutions Ltd. listed?

Entero Healthcare Solutions Ltd. is listed on NSE and BSE. The NSE symbol is ENTERO and the BSE code is -.

Where can I find the shareholding pattern of Entero Healthcare Solutions Ltd.?

The quarterly shareholding pattern of Entero Healthcare Solutions Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Entero Healthcare Solutions Ltd. on Sharpely?

Share price data for Entero Healthcare Solutions Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.